ENHT yields 2000000.00% · ABBV yields 3.06%● Live data
📍 ENHT pulled ahead of the other in Year 1
Combined, ENHT + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENHT + ABBV for your $10,000?
enherent Corp. operates as an information technology (IT) services company in the northeastern United States. The company offers IT consultative resource and staffing services to augment client resource demands in the areas of project management, business analysis, systems architecture and design, database architecture and design, application code development, network engineering, and quality assurance and testing. Its application development services comprise planning, design, application code development, testing, and deployment of enhancements to existing systems or new custom application development; and evaluation and implementation of third party business application software. The company's network and security services include planning, architecture, design, and engineering to support the build out, optimization, and security audits of the network infrastructure, as well as implementation of software product licenses or computer equipment. It also provides systems integration services, such as conducting application, data, and technical assessments to determining gaps in the existing environment; making recommendations to address the gaps by leveraging existing IT assets; deploying a combination of application code development, software product implementation, and computer equipment; and integrating new capabilities into the environment to address the gaps. In addition, the company offers advanced analytics that leverages text analytics technology to understand and process free-form text. It serves insurance, financial services, banking and capital markets, retail distribution, apparel, health care, pharmaceutical, and consumer goods industries. The company is headquartered in Syosset, New York.
Full ENHT Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.